Stock listing

DCTH Stock Price, News, Filings & Events — Delcath Systems, Inc.

Selected listing: DCTH · NASDAQ · USD · US

This page tracks Delcath Systems, Inc.'s DCTH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DCTH:NASDAQ. DCTH:NASDAQ is the stock-level entry point for investors researching Delcath Systems, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Delcath Systems, Inc. is a public company traded under the ticker DCTH in the American market. The company has a market capitalization of approximately $442.2 million. Delcath focuses on developing innovative therapies for cancer treatment.

DCTH:NASDAQUSDUSUpdated July 31, 2026
Delcath Systems, Inc. logo
Ticker
DCTH:NASDAQ
Asset type
Stock
Market cap
$421.9M
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD

Delcath Systems, Inc. DCTH:NASDAQ stock context

This page tracks Delcath Systems, Inc.'s DCTH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DCTH:NASDAQ. DCTH:NASDAQ is the stock-level entry point for investors researching Delcath Systems, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Delcath Systems, Inc. is a public company traded under the ticker DCTH in the American market. The company has a market capitalization of approximately $442.2 million. Delcath focuses on developing innovative therapies for cancer treatment.

Latest news from Delcath Systems, Inc.

All Delcath Systems, Inc. news →

Delcath Systems, Inc. earnings calls

Research Delcath Systems, Inc.

Alternate listings